SFT
BIIB icon

Simmons First Trust’s Biogen BIIB Stock Holding History

Simmons First Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$242K Buy
+790
New +$227K 0.03% 262

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Simmons First Trust's BIIB Position: Q4 2015 in Review

Simmons First Trust opened a new position in Biogen (BIIB) in Q4 2015: 790 shares worth $242K. The stake represents 0.03% of the portfolio and ranks #262 among its holdings.

969 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Simmons First Trust held 790 shares of Biogen worth $242K as of Q4 2015.
  • Biogen was a new Simmons First Trust position in Q4 2015.
  • Biogen made up 0.03% of Simmons First Trust's portfolio in Q4 2015, its #262 holding.
  • 969 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Simmons First Trust's 13F filing for Q4 2015, filed 1 Feb 2016.